UNPA / Farm bill becomes law; FDA’s Gottlieb issues statement on status of cannabis, CBD and use in dietary supplements
In an early Christmas gift to many consumers and various industries, the president today signed the 2018 farm bill, which includes the Hemp Farming Act of 2018. The passage of this legislation ends the 80-year listing of non-psychoactive cannabis as a Schedule 1 drug.
Moments after the bill being signed into law, FDA Commissioner Scott Gottlieb issued a statement, addressing and clarifying the agency’s position on hemp and cannabis derivatives, acknowledging the widespread consumer interest and use of these products.
Read Gottlieb’s full statement here.
Gottlieb also announced that the agency would hold a public meeting in the near future for stakeholders to share their experiences and challenges with these products.
We will certainly provide more information as it becomes available.
With warm regards,
Larisa and Frank